ArticleJournal of orthopaedic case reports2025
Dry Gangrene of Hand Secondary to Repetitive Intravenous Drug Abuse: A Case Series.
Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Inadvertent intra-arterial drug injection is a serious complication of intravenous (IV) drug use that can lead to severe vascular damage, including ischemia, gangrene, and amputation. Although such cases are well-documented, there is limited emphasis on the importance of early diagnosis and intervention in preventing severe outcomes. This case series reports on patients who experienced gangrene of the upper limbs as a result of IVintravenous drug use, highlighting the significant clinical consequences of delayed treatment. Case Report: We present a series of five male patients aged 21 to -30 years who presented with upper limb gangrene caused by repetitive IVintravenous drug use. The patients, all of whom were positive for human immunodeficiency virus HIV or Hepatitis C, had varying durations of drug abuse, with their symptoms ranging from 10 to 30 days before presentation. The clinical findings included dry gangrene, pain, and blackening of fingers, requiring surgical interventions such as partial or complete amputation. Diagnostic imaging such as Doppler ultrasound and computed tomography CT angiography was not performed in some cases due to patient refusal or financial constraints. Conclusion: This case series emphasises emphasizes the critical need for early recognition and timely intervention in cases of IVintravenous drug-induced ischemia. Surgical management was necessary in all cases, but earlier medical treatments, including vasodilators and thrombolytics, may have improved outcomes. This report serves to increase awareness of the complications associated with IVintravenous drug use. It underscores the need for healthcare providers to be vigilant in promptly diagnosing and managing such cases. The clinical impact extends beyond orthopaedics, contributing to the broader understanding of vascular complications related to IVintravenous drug abuse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.